C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
SING Equity

SING

OTCMKTS · SING

$0.00
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 3/5
39/100 composite
Fundamentals36
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

SinglePoint Inc (SING) merits a Neutral rating, maintaining a stance of moderation between the optimistic and pessimistic ends of the spectrum. With a composite score of 39.4, SinglePoint hovers in a region defined by cautious conviction, standing at a 3 out of 5 on the conviction scale. The pillar contributions prominently highlight regulatory aspects as the strongest factor, set at 49.0, underscoring compliance and stability even amidst other uneven performances.

The company's stagnant revenue growth, experiencing a year-over-year decline, coupled with significantly negative operating margins, paints a challenging financial landscape for SinglePoint. This scenario is compounded by a "stretched" financial condition that is hard to ignore, with liquidity pressures evident. Despite a gross margin that reflects some operational efficiency, cash management and overall profitability remain critically undermined by substantial net losses. Regular updates through primary regulatory filings remain absent, hence elevating the importance of monitoring these metrics closely as key indicators of corporate health.

Looking forward, the regulatory landscape continues to serve as a pivotal aspect for SinglePoint. With no immediate enforcement actions or non-compliance issues identified, the company does benefit from a stable jurisdiction standing. This regulatory reliability provides a foundation upon which future business maneuvers could potentially be leveraged. As SinglePoint navigates the uncertain dynamics of both financial pressures and market positioning, the ongoing alignment with jurisdictional expectations remains the key signal to monitor closely. The consistency and quality of forthcoming regulatory inscriptions offer the clearest lens through which to forecast potential shifts in corporate fortune.

Scored: 2026-08-23Valid through: 2026-10-07Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
2137 Phoenix, AZ 85016
CEO
Wil Ralston
CFO
Corey Lambrecht
SEC CIK
0001443611
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$0.0M
Enterprise value
$2.6M
Price to book
0.07
EV / EBITDA
-1.84
Revenue (TTM)
$20.3M
Gross profit (TTM)
$7.4M
EBITDA
$-9.6M
Operating margin
-41.8%
Profit margin
-142.7%
Rev growth YoY
-6.8%
Return on equity
0.0%
Return on assets
-62.0%
EPS (TTM)
$-3.58
Shares outstanding
79.8M
Insider ownership
0.0%
Beta
1.01
Full-time employees
60
GICS sector
Technology
GICS industry
Solar
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for SING (SING)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for SING (SING), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for SING are maintained by Cannabis Investor News and refreshed throughout the trading day.